Skip to main content

Zarrab fingers Erdogan in NY trial bombshell

Iranian-Turkish gold trader Reza Zarrab, testifying before a New York jury, has implicated President Recep Tayyip Erdogan and his former economy minister in a massive sanctions-busting scheme as Turkey does its frantic best to spin the story at home.
Turkey's President Tayyip Erdogan attends a news conference after the talks with Russia's President Vladimir Putin in Sochi, Russia November 13, 2017. REUTERS/Pavel Golovkin/Pool - UP1EDBD1JKFEI

Turkey’s government kicked into full defensive gear today as Reza Zarrab, an Iranian-Turkish gold trader, prepared to stand witness before a New York jury for a second day, continuing his account of a billion-dollar scam to smuggle gold for oil in violation of US sanctions on Iran and in collusion with top Turkish officials. The trial continued at the Federal District Court in Manhattan with allegations of further government malfeasance. The proceedings took a further sensational turn when Zarrab said Turkey's President Recep Tayyip Erdogan and former Economy Minister Ali Babacan had signed off on the scheme. “The prime minister at that time, Recep Tayyip Erdogan, … had given instructions, had given an order, for [Ziraat and Vakif banks] to start doing the trade,” Zarrab testified. He dropped this bombshell as allegations of further government corruption swirled at home.

Turkey’s deputy prime minister, Bekir Bozdag, told the state-run Anadolu news agency he did not expect justice from the federal court in New York. Zarrab is a star witness for the prosecution against Mehmet Hakan Atilla, the jailed deputy manager of the state-owned Halkbank, which figures prominently at the Turkish end of a multi-billion-dollar sanctions-busting scheme. Zarrab had become “a false witness under duress,” Bozdag claimed. “A theater is being staged in New York by the courts.”

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.